Wird geladen...
Phase I Study of Paclitaxel with Standard Dose Ifosfamide in Children with Refractory Solid Tumors: A Pediatric Oncology Group Study (POG 9376)
PURPOSE: A dose-escalation Phase I study of taxol (paclitaxel) administered in combination with standard dose ifosfamide was conducted in children with relapsed or refractory solid tumors. Primary objectives were to estimate the maximum-tolerated dose (MTD) and to describe the dose-limiting toxiciti...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2009
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2744894/ https://ncbi.nlm.nih.gov/pubmed/18989889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.21820 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|